2nd Quarter - Report

AMEDISYS, INC. for AMEDISYS, INC.

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Centers for Medicare and Medicaid policies, including the CY 2023 Home Health Prospective Payment System Rate Update, FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirement, HR 2471 the Consolidated Appropriations Act of 2022, S. 3792/HR 7053 the Hospital In-Patient Modernization Act of 2022, monitoring progress of Build Back Better legislation

LobbyistCovered position, as disclosed
DAVE KEMMERLY —
SCOTT M. LEVY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2471 (117th), H.R. 7053 (117th), S. 3792 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.